» Articles » PMID: 34201535

Therapeutic Potential of α-Crystallins in Retinal Neurodegenerative Diseases

Overview
Date 2021 Jul 2
PMID 34201535
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The chaperone and anti-apoptotic activity of α-crystallins (αA- and αB-) and their derivatives has received increasing attention due to their tremendous potential in preventing cell death. While originally known and described for their role in the lens, the upregulation of these proteins in cells and animal models of neurodegenerative diseases highlighted their involvement in adaptive protective responses to neurodegeneration associated stress. However, several studies also suggest that chronic neurodegenerative conditions are associated with progressive loss of function of these proteins. Thus, while external supplementation of α-crystallin shows promise, their potential as a protein-based therapeutic for the treatment of chronic neurodegenerative diseases remains ambiguous. The current review aims at assessing the current literature supporting the anti-apoptotic potential of αA- and αB-crystallins and its potential involvement in retinal neurodegenerative diseases. The review further extends into potentially modulating the chaperone and the anti-apoptotic function of α-crystallins and the use of such functionally enhanced proteins for promoting neuronal viability in retinal neurodegenerative disease.

Citing Articles

Key Role of Phosphorylation in Small Heat Shock Protein Regulation via Oligomeric Disaggregation and Functional Activation.

Sluzala Z, Hamati A, Fort P Cells. 2025; 14(2).

PMID: 39851555 PMC: 11764305. DOI: 10.3390/cells14020127.


Decreased Hsp90 activity protects against TDP-43 neurotoxicity in a C. elegans model of amyotrophic lateral sclerosis.

Garcia-Toscano L, Currey H, Hincks J, Stair J, Lehrbach N, Liachko N PLoS Genet. 2024; 20(12):e1011518.

PMID: 39724103 PMC: 11709271. DOI: 10.1371/journal.pgen.1011518.


Novel mTORC2/HSPB4 Interaction: Role and Regulation of HSPB4 T148 Phosphorylation.

Sluzala Z, Shan Y, Elghazi L, Cardenas E, Hamati A, Garner A Cells. 2024; 13(23).

PMID: 39682748 PMC: 11640050. DOI: 10.3390/cells13232000.


αB-crystallin mini-peptides support corneal healing and in rabbit model.

Maity N, Konar A, Hazra S Int J Ophthalmol. 2024; 17(10):1772-1779.

PMID: 39430030 PMC: 11422379. DOI: 10.18240/ijo.2024.10.02.


Cholesterol Content Regulates the Interaction of αA-, αB-, and α-Crystallin with the Model of Human Lens-Lipid Membranes.

Timsina R, Hazen P, Trossi-Torres G, Khadka N, Kalkat N, Mainali L Int J Mol Sci. 2024; 25(3).

PMID: 38339200 PMC: 10855794. DOI: 10.3390/ijms25031923.


References
1.
Yan H, Peng Y, Huang W, Gong L, Li L . The Protective Effects of B-Crystallin on Ischemia-Reperfusion Injury in the Rat Retina. J Ophthalmol. 2017; 2017:7205408. PMC: 5643040. DOI: 10.1155/2017/7205408. View

2.
Horwitz J, Bova M, Ding L, Haley D, Stewart P . Lens alpha-crystallin: function and structure. Eye (Lond). 2000; 13 ( Pt 3b):403-8. DOI: 10.1038/eye.1999.114. View

3.
Sakaguchi H, Miyagi M, Darrow R, Crabb J, Hollyfield J, Organisciak D . Intense light exposure changes the crystallin content in retina. Exp Eye Res. 2003; 76(1):131-3. DOI: 10.1016/s0014-4835(02)00249-x. View

4.
Yaung J, Kannan R, Wawrousek E, Spee C, Sreekumar P, Hinton D . Exacerbation of retinal degeneration in the absence of alpha crystallins in an in vivo model of chemically induced hypoxia. Exp Eye Res. 2008; 86(2):355-65. PMC: 2731668. DOI: 10.1016/j.exer.2007.11.007. View

5.
Sharma K, Santhoshkumar P . Lens aging: effects of crystallins. Biochim Biophys Acta. 2009; 1790(10):1095-108. PMC: 2743770. DOI: 10.1016/j.bbagen.2009.05.008. View